Published in J Immunol on January 15, 1992
Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol (1997) 2.28
Interleukin-18 and IL-18 binding protein. Front Immunol (2013) 1.93
Epstein-barr virus-induced changes in B-lymphocyte gene expression. J Virol (2002) 1.72
Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther (2006) 1.58
IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis (2006) 1.54
Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci U S A (2008) 1.38
Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci U S A (2008) 1.37
Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A (2006) 1.32
Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol (2008) 1.19
Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics (2010) 1.15
Interleukin-32 expression in the pancreas. J Biol Chem (2009) 1.14
A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res (2011) 1.12
Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol (2007) 1.12
Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther (2010) 1.03
A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10. Immunology (2008) 1.03
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals. Oncogene (2011) 1.03
Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc Natl Acad Sci U S A (2011) 1.02
Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS One (2009) 0.99
Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood (2011) 0.97
Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One (2010) 0.96
Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem (2011) 0.94
Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infect Immun (2012) 0.93
Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3. Immunology (2012) 0.91
Molecular characterization of IL-32 in human endothelial cells. Cytokine (2009) 0.90
The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. J Immunol (2011) 0.90
Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chem Biol (2009) 0.88
Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy (2011) 0.88
Elevated serum level of interleukin-32α in the patients with myasthenia gravis. J Neurol (2011) 0.87
IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther (2012) 0.86
IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis. Sci Rep (2013) 0.85
Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha. Arthritis Res Ther (2012) 0.83
The role of IL-32 in cutaneous T-cell lymphoma. J Invest Dermatol (2013) 0.83
Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32. Cancer Gene Ther (2011) 0.82
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling. Oncotarget (2015) 0.82
Expression levels of novel cytokine IL-32 in periodontitis and its role in the suppression of IL-8 production by human gingival fibroblasts stimulated with Porphyromonas gingivalis. J Oral Microbiol (2012) 0.81
Construction of an approximately 700-kb transcript map around the familial Mediterranean fever locus on human chromosome 16p13.3. Genome Res (1998) 0.80
Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10. BMC Infect Dis (2014) 0.80
Gene Expressions for Signal Transduction under Acidic Conditions. Genes (Basel) (2013) 0.79
A human dendritic cell subset receptive to the Venezuelan equine encephalitis virus-derived replicon particle constitutively expresses IL-32. J Immunol (2008) 0.79
Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS. Curr Cancer Ther Rev (2009) 0.79
IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis. Mediators Inflamm (2016) 0.79
Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues. BMC Res Notes (2014) 0.78
NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS One (2015) 0.78
Role of interleukin-32 in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol (2013) 0.78
Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas. BMC Cancer (2009) 0.77
Elevated interleukin-32 expression is associated with Helicobacter pylori-related gastritis. PLoS One (2014) 0.77
Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells. Respir Res (2012) 0.77
Genome-based expression profiling study of Hunner's ulcer type interstitial cystitis: an array of 40-gene model. Int Urogynecol J (2010) 0.76
Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification. Oncotarget (2014) 0.76
Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection. Viruses (2015) 0.76
A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation. Eur J Med Res (2015) 0.76
Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia. Clin Exp Immunol (2013) 0.76
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice. Oncotarget (2015) 0.75
Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway. J Virol (2015) 0.75
The history of fever, leukocytic pyrogen and interleukin-1. Temperature (Austin) (2015) 0.75
Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma. Oncol Lett (2011) 0.75
IL-32γ delays spontaneous apoptosis of human neutrophils through MCL-1, regulated primarily by the p38 MAPK pathway. PLoS One (2014) 0.75
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis. Sci Rep (2017) 0.75
Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice. Oncotarget (2015) 0.75
Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors. Sci Rep (2016) 0.75
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1992) 0.75
IL-32α-induced inflammation constitutes a link between obesity and colon cancer. Oncoimmunology (2017) 0.75
Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review. Inflammation (2016) 0.75
Modeling gene expression with differential equations. Pac Symp Biocomput (1999) 2.85
Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature (1985) 1.82
A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics (1993) 1.12
Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies. JAMA (2000) 1.06
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation (1992) 1.03
Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J Virol (2000) 1.03
DNA and protein studies of HLA class II molecules: their relationship to T cell recognition. Immunol Rev (1985) 0.92
Evolutionary and genetic implications of sequence variation in two nonallelic HLA-DR beta-chain cDNA sequences. Proc Natl Acad Sci U S A (1987) 0.82
Molecular cloning and expression analysis of the ethylene insensitive3 (EIN3) gene in cucumber (Cucumis sativus). Genet Mol Res (2013) 0.81
In vitro differentiation of mouse embryonic yolk sac cells. Differentiation (1987) 0.80
Plasma propofol concentrations during orthotopic liver transplantation. Acta Anaesthesiol Scand (2005) 0.79
A monoclonal antibody (RH1-38) which inhibits multiple systems of cell-mediated cytotoxicity--II. Evidence that the epitope recognized is involved in a late step in the cytolytic mechanism. Mol Immunol (1985) 0.79
Isolation of a cDNA clone encoding a novel form of granzyme B from human NK cells and mapping to chromosome 14. Hum Genet (1990) 0.77
Granulocyte-macrophage colony-stimulating factor augmentation of T-cell receptor-dependent and T-cell receptor-independent thymocyte proliferation. Blood (1994) 0.76
[Immunohistochemical and electron microscopic study of thyroid peroxidase in endemic goiter]. Zhonghua Bing Li Xue Za Zhi (1986) 0.75
Proto-oncogene transcription after activation of Th-1 and Th-2 cells. Ann N Y Acad Sci (1991) 0.75
A rapid method for determining the relationship between cDNA clones. Biotechniques (1990) 0.75
DQ beta sequences in HLA-DR4 haplotypes. Hum Immunol (1987) 0.75
Effects of FK 506 and cyclosporine on T-cell tolerance: inhibition of a "protective" mechanism that regulates activation-induced apoptosis in developing thymocytes. Transplant Proc (1991) 0.75
HIV infections: the global epidemiology and goals for vaccine research. Mol Med (2000) 0.75
Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction. Blood (1993) 0.75
Ia antigens on murine epididymal fat pad endothelial cells. Immunohistology and mixed lymphocyte endothelial cell culture studies. Transplantation (1987) 0.75